OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Integrated drug profiling and CRISPR screening identify BCR::ABL1-independent vulnerabilities in chronic myeloid leukemia
Shady Adnan Awad, Olli Dufva, Jay Klievink, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 5, pp. 101521-101521
Open Access | Times Cited: 7
Shady Adnan Awad, Olli Dufva, Jay Klievink, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 5, pp. 101521-101521
Open Access | Times Cited: 7
Showing 7 citing articles:
MDM2 inhibitors induce apoptosis by suppressing MDM2 and enhancing p53, Bax, Puma and Noxa expression levels in imatinib‑resistant chronic myeloid leukemia cells
Akihiro Kimura, Masanobu Tsubaki, Teruki Obana, et al.
Biomedical Reports (2025) Vol. 22, Iss. 4
Open Access | Times Cited: 1
Akihiro Kimura, Masanobu Tsubaki, Teruki Obana, et al.
Biomedical Reports (2025) Vol. 22, Iss. 4
Open Access | Times Cited: 1
The present and future of the Cancer Dependency Map
Rand Arafeh, Tsukasa Shibue, Joshua M. Dempster, et al.
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 8
Rand Arafeh, Tsukasa Shibue, Joshua M. Dempster, et al.
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 8
Unifying Genetic and Chemical Perturbagen Representation through a Hybrid Deep Learning Framework
Yiming Li, Jun Zhu, Linjing Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Yiming Li, Jun Zhu, Linjing Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
CML stem cells and their interactions and adaptations to tyrosine kinase inhibitors
Stein‐Erik Gullaksen, Maria Omsland, Mathias Brevik, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2025), pp. 1-10
Open Access
Stein‐Erik Gullaksen, Maria Omsland, Mathias Brevik, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2025), pp. 1-10
Open Access
Harnessing p53 for targeted cancer therapy: new advances and future directions
Zdeněk Andrysík, Joaquı́n M. Espinosa
Transcription (2025), pp. 1-44
Open Access
Zdeněk Andrysík, Joaquı́n M. Espinosa
Transcription (2025), pp. 1-44
Open Access
A network-based approach to overcome BCR::ABL1-independent resistance in chronic myeloid leukemia
Valeria Bica, Veronica Venafra, Giorgia Massacci, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
Valeria Bica, Veronica Venafra, Giorgia Massacci, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
Integrated functional genomic screening to bypass TKI resistance in chronic myeloid leukemia
Tumas Beinortas, Brian J.P. Huntly
Cell Reports Medicine (2024) Vol. 5, Iss. 5, pp. 101565-101565
Open Access
Tumas Beinortas, Brian J.P. Huntly
Cell Reports Medicine (2024) Vol. 5, Iss. 5, pp. 101565-101565
Open Access
